Increases in seizure latencies induced by subcutaneous docosahexaenoic acid are lost at higher doses.

Docosahexaenoic acid (DHA) is a polyunsaturated fatty acid (PUFA) which has been found to have anticonvulsant properties. Our group has previously reported in a pilot study that the acute administration of subcutaneous (s.c.